Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

TELESTA THERAPEUTICS INC T.TST

"Telesta Therapeutics Inc is a biopharmaceutical company. The Company is engaged in the research, development, manufacturing and commercialization of human health products and technologies."


TSX:TST - Post by User

Post by thePlayeron Apr 28, 2013 5:28pm
184 Views
Post# 21311724

The Demand

The Demand

 

Bioniche dissidents demand meeting to replace board

2013-04-25 19:06 ET - Shareholders Letter

 

Mr. William Wells, concerned shareholder, reports

CONCERNED BIONICHE SHAREHOLDERS REQUISITION SPECIAL MEETING OF SHAREHOLDERS TO REPLACE THE BOARD

A group of concerned shareholders of Bioniche Life Sciences Inc. led by William (Bill) M. Wells, former chief executive officer of Biovail Corp., and Greg Gubitz, former general counsel and senior vice-president of corporate development at Biovail Corp., has formally requisitioned a special meeting of the shareholders of Bioniche in order to replace the company's board of directors.

The overwhelmingly positive reaction of our fellow shareholders to our open letter to the board has confirmed our view of the deep dissatisfaction of Bioniche's shareholders with the company's management and performance.

Bioniche's board and management have no credibility given their consistent and continued failure to deliver on past promises in the face of a steady decline in the company's business and prospects and erosion of shareholder value.

We believe there is no alternative other than a fresh start. Bioniche's existing management and board have failed. We believe that Bioniche has potential to become a great Canadian life sciences company with the right leadership and proper business focus. It is time for new direction and new leadership.

Many of the Bioniche shareholders who contacted us have asked how we propose to turn the company around and improve the prospects of enhancing shareholder value. We look forward to answering these questions in detail as part of our solicitation of shareholder proxies leading up to the special shareholders meeting.

We trust the Bioniche board will act quickly to promptly call the special shareholders meeting so that the company's long-suffering shareholders can have their say.

-----------------------------------------------------

just in case if you somehow skipped The CHART here it is:

(Bioniche's history of annual loses and share price decline)

https://files.newswire.ca/678/BiovailChart.pdf

 

 

<< Previous
Bullboard Posts
Next >>